Vanguard Group Inc Johnson & Johnson Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Vanguard Group Inc holds 236,618,586 shares of JNJ stock, worth $45.9 Billion. This represents 0.68% of its overall portfolio holdings.

Number of Shares

236,618,586

Previous 237,047,859 0.18%

Holding current value

$45.9 Billion

Previous $36.2 Billion 21.17%

% of portfolio

0.68%

Previous 0.61%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$155.17 - $185.42 $66.6 Million - $79.6 Million	-429,273 Reduced 0.18%	236,618,586 $43.9 Billion
Q2 2025 Aug 11, 2025	BUY	$146.36 - $159.82 $452 Million - $493 Million	3,085,180 Added 1.32%	237,047,859 $36.2 Billion
Q1 2025 May 09, 2025	BUY	$142.06 - $167.7 $166 Million - $196 Million	1,170,120 Added 0.5%	233,962,679 $38.8 Billion
Q4 2024 Feb 11, 2025	BUY	$143.34 - $165.86 $254 Million - $294 Million	1,772,706 Added 0.77%	232,792,559 $33.7 Billion
Q3 2024 Nov 13, 2024	BUY	$145.48 - $167.38 $288 Million - $331 Million	1,978,057 Added 0.86%	231,019,853 $37.4 Billion
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $14.9 Million - $16.3 Million	103,292 Added 0.05%	229,041,796 $33.5 Billion
Q1 2024 May 10, 2024	SELL	$155.22 - $162.74 $69.7 Million - $73.1 Million	-449,167 Reduced 0.2%	228,938,504 $36.2 Billion
Q4 2023 Mar 11, 2024	BUY	$145.6 - $158.88 $6,552 - $7,149	45 Added 0.0%	229,387,671 $36 Billion
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $14.7 Million - $16 Million	100,891 Added 0.04%	229,387,626 $36 Billion
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $2.83 Billion - $3.17 Billion	-18,192,091 Reduced 7.35%	229,286,735 $35.7 Billion
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $84.7 Million - $91.1 Million	548,469 Added 0.22%	247,478,826 $41 Billion
Q1 2023 Jul 14, 2023	BUY	$151.05 - $180.26 $2.44 Million - $2.92 Million	16,174 Added 0.01%	246,930,357 $38.3 Billion
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $13.2 Million - $15.8 Million	87,562 Added 0.04%	246,914,183 $38.3 Billion
Q4 2022 Feb 10, 2023	BUY	$160.2 - $179.79 $238 Million - $267 Million	1,485,746 Added 0.61%	246,826,621 $43.6 Billion
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $454 Million - $505 Million	2,815,655 Added 1.16%	245,340,875 $40.1 Billion
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $737 Million - $815 Million	4,384,110 Added 1.84%	242,525,220 $43.1 Billion
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $531 Million - $603 Million	3,358,478 Added 1.43%	238,141,110 $42.2 Billion
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $203 Million - $226 Million	1,303,457 Added 0.56%	234,782,632 $40.2 Billion
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $331 Million - $367 Million	2,046,807 Added 0.88%	233,479,175 $37.7 Billion
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $36.9 Billion - $39.6 Billion	231,432,368 New	231,432,368 $38.1 Billion

Others Institutions Holding JNJ

# of Institutions

4,768

Shares Held

1.76B

Call Options Held

18M

Put Options Held

14.7M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $507B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Johnson & Johnson Transaction History